Healthcare
Ryman Healthcare Limited(RYHTY)
Live Price
Offline$6.11
+0.00% today
1Y Change
-15.84%
Window
Jun 23, 2025 โ Jun 17, 2026
- Market Cap
- $2.20B
- Revenue Growth
- +9.7%
- EPS Growth
- -8940.6%
- Dividend Yield
- 0.0%
Coverage: 248 bars ยท Jun 23, 2025 โ Jun 17, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Ryman Healthcare Limited (RYHTY) is a Healthcare stock with a market cap of $2.20B and listed on OTC. The stock last traded around $6.11 and down 15.8% across the available one-year price window (Jun 23, 2025 โ Jun 17, 2026). Baseline metrics include revenue growth of +9.7%, EPS growth of -8940.6%, a dividend yield of 0.0%. What stands out right now is revenue +9.7%, EPS -8940.6%, free cash flow -37.7% with operating margin -8.1% and ROIC -0.5%. Valuation is more restrained than many high-expectation growth names at price/sales 2.9. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines RYHTY price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Above sector median
+9.7% vs +7.6% peer median
Operating Margin
Below sector median
-8.1% vs +19.4% peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on May 26, 2026, but the surprise data is still limited.
The operating picture looks softer than before
Revenue is at +9.7% and EPS is at -8940.6%, with operating margin around -8.1%.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged -2.7% over the next 5 trading days and finished higher after 0 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 May 26, 2026 | โ | +0.0% | +0.0% | โ |
2025 Nov 25, 2025 | โ | +0.0% | +0.0% | +4.4% |
2025 May 25, 2025 | โ | +0.0% | -8.0% | -2.9% |
Benchmark Comparison
Normalized Performance vs SPY
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
RYHTY
โ
Normalized return
SPY
โ
S&P 500
Excess Return
โ
Relative to SPY
RYHTY Max Drawdown
-28.99%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for RYHTY and SPY.
Company Overview
Ryman Healthcare Limited
Other OTC
Ryman Healthcare Limited develops, owns, and operates integrated retirement villages, rest homes, and hospitals for the elderly in New Zealand and Australia. The company's villages provide a range of retirement living and care options, such as independent townhouses and apartments, and serviced apartments, as well as a care center, which offers rest homes, hospitals, dementia-level care, and respite and day care services. Its villages also provide all-weather bowling green, indoor heated swimming pool and spa, gym, internal atrium, beauty and hairdressing salons, library, dining room, internet cafรฉ, bar, lounges, croquet laws, shops, and movie theatre facilities. As of May 20, 2022, Ryman Healthcare Limited owned and operated 45 retirement villages with approximately 8,538 retirement village units and 4,239 care units. The company was founded in 1984 and is based in Christchurch, New Zealand.
- Leadership
- Naomi James
- IPO Date
- Jan 11, 2013
- Employees
- 7.7k
- Street Address
- Airport Business Park
- Mailing
- Christchurch, 8042
- Region
- Christchurch, NZ
- Reporting Currency
- USD
- Investor Line
- 64 3 366 4069
- Last Updated
- May 4, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- โ
- EV/EBITDA
- โ
- Price/Sales
- 2.9
- Price/Book
- 0.5
Growth
- Revenue
- +9.7%
- EPS
- -8940.6%
- Free Cash Flow
- -37.7%
Profitability
- Gross Margin
- -8.1%
- Operating Margin
- -8.1%
- Net Margin
- -75.9%
- ROE
- -13.7%
- ROIC
- -0.5%
Balance Sheet
- Debt/Equity
- 0.40
- Current Ratio
- 0.87
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.